Cough in idiopathic pulmonary fibrosis

Mirjam J G van Manen, Surinder S Birring, Carlo Vancheri, Vincent Cottin, Elisabetta A Renzoni, Anne-Marie Russell, Marlies S Wijsenbeek, Mirjam J G van Manen, Surinder S Birring, Carlo Vancheri, Vincent Cottin, Elisabetta A Renzoni, Anne-Marie Russell, Marlies S Wijsenbeek

Abstract

Many patients with idiopathic pulmonary fibrosis (IPF) complain of chronic refractory cough. Chronic cough is a distressing and disabling symptom with a major impact on quality of life. During recent years, progress has been made in gaining insight into the pathogenesis of cough in IPF, which is most probably "multifactorial" and influenced by mechanical, biochemical and neurosensory changes, with an important role for comorbidities as well. Clinical trials of cough treatment in IPF are emerging, and cough is increasingly included as a secondary end-point in trials assessing new compounds for IPF. It is important that such studies include adequate end-points to assess cough both objectively and subjectively. This article summarises the latest insights into chronic cough in IPF. It describes the different theories regarding the pathophysiology of cough, reviews the different methods to assess cough and deals with recent and future developments in the treatment of cough in IPF.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at err.ersjournals.com

Copyright ©ERS 2016.

Figures

FIGURE 1
FIGURE 1
Pathophysiology of cough. TRPV1: transient receptor potential vanilloid 1; TRPA1: transient receptor potential ankyrin 1; RAR: rapidly adapting receptor; SAR: slowly adapting receptor. Reproduced from [17] with permission from the publisher.
FIGURE 2
FIGURE 2
Interactions between idiopathic pulmonary fibrosis (IPF), gastro-oesophageal reflux disease (GORD), obstructive sleep apnoea (OSA) and cough. 1: traction leading to a weaker lower oesophageal sphincter tonus [45]; 2: microaspiration inducing epithelial damage [38, 46]; 3: restriction inducing instability of the upper airway [39]; 4: intermitted hypoxaemia promoting profibrotic mechanisms [49]; 5: increased cough reflex sensitivity [–31]; 6: pressure causing stretch injury and activation of fibrotic mechanisms [31]; 7: microaspiration causing an inflammatory reaction blocking the airway [53]; 8: obstruction increasing trans-diaphragmatic pressure [51, 52]; 9: aspiration directly and acid reflux indirectly stimulate the cough reflex [6, 47]; 10: cough increasing trans-diaphragmatic pressure [47]; 11: less central inhibition and inflammation increasing cough reflex sensitivity [54].

References

    1. Raghu G, Collard HR, Egan JJ, et al. . An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011; 183: 788–824.
    1. Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA). The Voice of the Patient: A series of reports from the U.S. Food and Drug Administration's (FDA's) Patient-Focused Drug Development Initiative. Date last updated: March, 2015.
    1. King TE Jr, Bradford WZ, Castro-Bernardini S, et al. . A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2083–2092.
    1. Richeldi L, du Bois RM, Raghu G, et al. . Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 2014; 370: 2071–2082.
    1. Ryerson CJ, Abbritti M, Ley B, et al. . Cough predicts prognosis in idiopathic pulmonary fibrosis. Respirology 2011; 16: 969–975.
    1. Chung KF, Pavord ID. Prevalence, pathogenesis, and causes of chronic cough. Lancet 2008; 371: 1364–1374.
    1. Morice AH. Epidemiology of cough. Pulm Pharmacol Ther 2002; 15: 253–259.
    1. Hope-Gill BDM, Hilldrup S, Davies C, et al. . A study of the cough reflex in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003; 168: 995–1002.
    1. Swigris JJ, Stewart AL, Gould MK, et al. . Patients’ perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes 2005; 3: 61.
    1. Key AL, Holt K, Hamilton A, et al. . Objective cough frequency in idiopathic pulmonary fibrosis. Cough 2010; 6: 4.
    1. Van Manen M, Birring S, Vancheri C, et al. . Cough measurements in patients with idiopathic pulmonary fibrosis (IPF). Am J Respir Crit Care Med 2015; 191: A4422.
    1. Sumner H, Woodcock A, Kolsum U, et al. . Predictors of objective cough frequency in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 943–949.
    1. Dicpinigaitis PV. Cough reflex sensitivity in cigarette smokers. Chest 2003; 123: 685–688.
    1. Morice AH, Fontana GA, Belvisi MG, et al. . ERS guidelines on the assessment of cough. Eur Respir J 2007; 29: 1256–1276.
    1. Birring SS, Prudon B, Carr AJ, et al. . Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ). Thorax 2003; 58: 339–343.
    1. Bradaia F, Lazor R, Khouatra C, et al. . Incontinence urinaire a la toux au cours des pneumopathies interstitielles diffuses [Urinary incontinence due to chronic cough in interstitial lung disease]. Rev Mal Respir 2009; 26: 499–504.
    1. Lee K, Birring S. Cough. Medicine 2012; 40: 173–176.
    1. Pacheco A. Chronic cough: from a complex dysfunction of the neurological circuit to the production of persistent cough. Thorax 2014; 69: 881–883.
    1. Morice AH, Millqvist E, Belvisi MG, et al. . Expert opinion on the cough hypersensitivity syndrome in respiratory medicine. Eur Respir J 2014; 44: 1132–1148.
    1. Polverino M, Polverino F, Fasolino M, et al. . Anatomy and neuro-pathophysiology of the cough reflex arc. Multidiscip Respir Med 2012; 7: 5.
    1. Banner KH, Igney F, Poll C. TRP channels: emerging targets for respiratory disease. Pharmacol Ther 2011; 130: 371–384.
    1. Jones RM, Hilldrup S, Hope-Gill BD, et al. . Mechanical induction of cough in idiopathic pulmonary fibrosis. Cough 2011; 7: 2.
    1. Harrison NK, Pynn MC. Nerves, cough, and idiopathic pulmonary fibrosis. EMJ Respir 2015; 3: 38–45.
    1. Lieu TM, Myers AC, Meeker S, et al. . TRPV1 induction in airway vagal low-threshold mechanosensory neurons by allergen challenge and neurotrophic factors. Am J Physiol Lung Cell Mol Physiol 2012; 302: L941–L948.
    1. Harrison NK. Idiopathic pulmonary fibrosis: a nervous cough? Pulm Pharmacol Ther 2004; 17: 347–350.
    1. Doherty MJ, Mister R, Pearson MG, et al. . Capsaicin induced cough in cryptogenic fibrosing alveolitis. Thorax 2000; 55: 1028–1032.
    1. Harrison NK. Cough, sarcoidosis and idiopathic pulmonary fibrosis: raw nerves and bad vibrations. Cough 2013; 9: 9.
    1. Ricci A, Felici L, Mariotta S, et al. . Neurotrophin and neurotrophin receptor protein expression in the human lung. Am J Respir Cell Mol Biol 2004; 30: 12–19.
    1. Ricci A, Graziano P, Bronzetti E, et al. . Increased pulmonary neurotrophin protein expression in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2007; 24: 13–23.
    1. Olgart Höglund C, de Blay F, Oster JP, et al. . Nerve growth factor levels and localisation in human asthmatic bronchi. Eur Respir J 2002; 20: 1110–1116.
    1. Leslie KO. Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis. Arch Pathol Lab Med 2012; 136: 591–600.
    1. Ghatol A, Ruhl AP, Danoff SK. Exacerbations in idiopathic pulmonary fibrosis triggered by pulmonary and nonpulmonary surgery: a case series and comprehensive review of the literature. Lung 2012; 190: 373–380.
    1. Mazzone SB, McLennan L, McGovern AE, et al. . Representation of capsaicin-evoked urge-to-cough in the human brain using functional magnetic resonance imaging. Am J Respir Crit Care Med 2007; 176: 327–332.
    1. Leech J, Mazzone SB, Farrell MJ. Brain activity associated with placebo suppression of the urge-to-cough in humans. Am J Respir Crit Care Med 2013; 188: 1069–1075.
    1. Madison JM, Irwin RS. Chronic cough in adults with interstitial lung disease. Curr Opin Pulm Med 2005; 11: 412–416.
    1. Lamas DJ, Kawut SM, Bagiella E, et al. . Delayed access and survival in idiopathic pulmonary fibrosis: a cohort study. Am J Respir Crit Care Med 2011; 184: 842–847.
    1. Tobin RW, Pope CE 2nd, Pellegrini CA, et al. . Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1804–1808.
    1. Pillai M, Olson AL, Huie TJ, et al. . Obstructive sleep apnea does not promote esophageal reflux in fibrosing interstitial lung disease. Respir Med 2012; 106: 1033–1039.
    1. Mermigkis C, Stagaki E, Tryfon S, et al. . How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 2010; 14: 387–390.
    1. Lancaster LH, Mason WR, Parnell JA, et al. . Obstructive sleep apnea is common in idiopathic pulmonary fibrosis. Chest 2009; 136: 772–778.
    1. Fell CD. Idiopathic pulmonary fibrosis: phenotypes and comorbidities. Clin Chest Med 2012; 33: 51–57.
    1. Scholand MB, Wolff R, Crossno PF, et al. . Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype. Cough 2014; 10: 3.
    1. Horton MR, Santopietro V, Mathew L, et al. . Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial. Ann Intern Med 2012; 157: 398–406.
    1. Kreuter M, Ehlers-Tenenbaum S, Schaaf M, et al. . Treatment and outcome of lung cancer in idiopathic interstitial pneumonias. Sarcoidosis Vasc Diffuse Lung Dis 2015; 31: 266–274.
    1. Perng DW, Chang KT, Su KC, et al. . Exposure of airway epithelium to bile acids associated with gastroesophageal reflux symptoms: a relation to transforming growth factor-beta1 production and fibroblast proliferation. Chest 2007; 132: 1548–1556.
    1. Lee JS, Collard HR, Raghu G, et al. . Does chronic microaspiration cause idiopathic pulmonary fibrosis? Am J Med 2010; 123: 304–311.
    1. Ing AJ, Ngu MC, Breslin AB. Pathogenesis of chronic persistent cough associated with gastroesophageal reflux. Am J Respir Crit Care Med 1994; 149: 160–167.
    1. Kilduff CE, Counter MJ, Thomas GA, et al. . Effect of acid suppression therapy on gastroesophageal reflux and cough in idiopathic pulmonary fibrosis: an intervention study. Cough 2014; 10: 4.
    1. Mermigkis C, Bouloukaki I, Antoniou K, et al. . Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath 2015; 19: 385–391.
    1. Birring SS, Ing AJ, Chan K, et al. . Obstructive sleep apnoea: a cause of chronic cough. Cough 2007; 3: 7.
    1. Jung HK, Choung RS, Talley NJ. Gastroesophageal reflux disease and sleep disorders: evidence for a causal link and therapeutic implications. J Neurogastroenterol Motil 2010; 16: 22–29.
    1. Chan KK, Ing AJ, Laks L, et al. . Chronic cough in patients with sleep-disordered breathing. Eur Respir J 2010; 35: 368–372.
    1. Eskiizmir G, Kezirian E. Is there a vicious cycle between obstructive sleep apnea and laryngopharyngeal reflux disease? Med Hypotheses 2009; 73: 706–708.
    1. Chan K, Ing A, Birring SS. Cough in obstructive sleep apnoea. Pulm Pharmacol Ther 2015; 35: 129–131.
    1. Boulet LP, Coeytaux RR, McCrory DC, et al. . Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report. Chest 2015; 147: 804–814.
    1. Lee KK, Matos S, Evans DH, et al. . A longitudinal assessment of acute cough. Am J Respir Crit Care Med 2013; 187: 991–997.
    1. Lechtzin N, Hilliard ME, Horton MR. Validation of the cough quality-of-life questionnaire in patients with idiopathic pulmonary fibrosis. Chest 2013; 143: 1745–1749.
    1. Morice AH, Kastelik JA, Thompson R. Cough challenge in the assessment of cough reflex. Br J Clin Pharmacol 2001; 52: 365–375.
    1. Spinou A, Birring SS. An update on measurement and monitoring of cough: what are the important study endpoints? J Thorac Dis 2014; 6: Suppl. 7, S728–S734.
    1. Birring SS, Spinou A. How best to measure cough clinically. Curr Opin Pharmacol 2015; 22: 37–40.
    1. Lee JS, Collard HR, Anstrom KJ, et al. . Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials. Lancet Respir Med 2013; 1: 369–376.
    1. Raghu G, Rochwerg B, Zhang Y, et al. . An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis. An update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 2015; 192: e3–e19.
    1. Azuma A, Taguchi Y, Ogura T, et al. . Exploratory analysis of a phase III trial of pirfenidone identifies a subpopulation of patients with idiopathic pulmonary fibrosis as benefiting from treatment. Respir Res 2011; 12: 143.
    1. Wijsenbeek MS, Van Beek FT, Geel AL, et al. . Pirfenidone in daily clinical use in patients with idiopathic pulmonary fibrosis in the Netherlands. Am J Respir Crit Care Med 2013; 187: A4340.
    1. Okazaki A, Ohkura N, Fujimura M, et al. . Effects of pirfenidone on increased cough reflex sensitivity in guinea pigs. Pulm Pharmacol Ther 2013; 26: 603–608.
    1. Vertigan AE, Kapela SL, Ryan NM, et al. . Pregabalin and speech pathology combination therapy for refractory chronic cough: a randomised controlled trial. Chest 2016; 149: 639–648.
    1. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet 2012; 380: 1583–1589.
    1. Patel AS, Watkin G, Willig B, et al. . Improvement in health status following cough-suppression physiotherapy for patients with chronic cough. Chron Respir Dis 2011; 8: 253–258.
    1. Abdulqawi R, Dockry R, Holt K, et al. . P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study. Lancet 2015; 385: 1198–1205.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe